MYCN and helicases DDX17 and DDX5 have opposite effects on the production of readthrough-associated chimeric transcripts
Valentine Clerc, Khouaila Aouadi, Jessica Valat, Xavier Grand, Lou-Sahra Khourab, Alizée Duquet, Nicolas Fontrodona, Matéo Bazire, Nicolas Rama, Didier Auboeuf, Benjamin Gibert, Franck Mortreux, Cyril F. Bourgeois · 2026
Read MYCN and helicases DDX17 and DDX5 have opposite effects on the production of readthrough-associated chimeric transcripts by Valentine Clerc, Khouaila Aouadi, Jessica Valat, Xavier Grand, Lou-Sahra Khourab, Alizée Duquet, Nicolas Fontrodona, Matéo Bazire, Nicolas Rama, Didier Auboeuf, Benjamin Gibert, Franck Mortreux, Cyril F. Bourgeois (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13429570.txt.
Description
Valentine Clerc and colleagues show how two helicases, DDX17 and DDX5, police where transcription stops in neuroblastoma cells. These enzymes manage the tail end of pre-messenger RNAs, and losing them lets reading run past gene ends.
Run-on reading then fuses tandem genes into chimeric transcripts, called tracRNAs, which pile up in high-risk tumours with poor survival. Low helicase levels tracked that risk and ran opposite to MYCN amplification. MYCN did not change helicase amounts, yet it bound gene tail regions, met DDX17, and bent termination toward fusion transcripts.
Catalog record
| CREATOR | Valentine Clerc, Khouaila Aouadi, Jessica Valat, Xavier Grand, Lou-Sahra Khourab, Alizée Duquet, Nicolas Fontrodona, Matéo Bazire, Nicolas Rama, Didier Auboeuf, Benjamin Gibert, Franck Mortreux, Cyril F. Bourgeois |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |